110 related articles for article (PubMed ID: 16964597)
41. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
42. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
43. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
44. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
[TBL] [Abstract][Full Text] [Related]
45. Donor age and outcome of liver transplantation.
Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
[TBL] [Abstract][Full Text] [Related]
46. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
48. Risk of extended criteria donors in hepatitis C virus-positive recipients.
Berenguer M
Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
[TBL] [Abstract][Full Text] [Related]
49. Is recurrent hepatitis C worse with living donors?
Kuo A; Terrault NA
Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
[TBL] [Abstract][Full Text] [Related]
50. Transplantation of kidneys from HCV-positive donors: a safe strategy?
Fabrizi F; Bunnapradist S; Lunghi G; Martin P
J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
[TBL] [Abstract][Full Text] [Related]
51. The use of hepatitis C-infected grafts in liver transplantation.
Arenas JI; Vargas HE; Rakela J
Liver Transpl; 2003 Nov; 9(11):S48-51. PubMed ID: 14586895
[TBL] [Abstract][Full Text] [Related]
52. The natural history of recurrent hepatitis C and what influences this.
Gane EJ
Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
[TBL] [Abstract][Full Text] [Related]
53. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
Gane E
Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
Maluf DG; Archer KJ; Villamil F; Stravitz RT; Mas V
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):445-58. PubMed ID: 20678018
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus infection in liver allografts.
Randhawa PS; Demetris AJ
Pathol Annu; 1995; 30 Pt 2():203-26. PubMed ID: 8570276
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
